Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2025)
Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Sector: Healthcare

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
CTMX	CYTOMX THERAPEUTICS INC	$233.80M	-553.10%	32.20%	86.63%	-811.10%	2.93	1.73	100.00%	28.20%	28.35%
ADMA	ADMA BIOLOGICS INC	$3.73B	61.80%	42.90%	32.10%	37.00%	0.40	5.33	53.00%	44.10%	32.73%
PRVA	PRIVIA HEALTH GROUP INC	$2.92B	2.50%	1.40%	3.90%	-552.80%	0.72	1.88	10.10%	0.90%	1.54%
CCRN	CROSS COUNTRY HEALTHCARE INC	$466.20M	-2.00%	-1.40%	-1.07%	-2.30%	0.34	3.21	20.20%	-0.70%	-0.41%
FLGC	FLORA GROWTH CORP	$12.21M	-298.10%	-52.00%	-146.63%	-274.80%	4.63	0.96	21.40%	-25.00%	-24.80%
CLOV	CLOVER HEALTH INVESTMENTS CORP	$1.63B	-7.50%	-4.00%	-6.82%	-17.90%	0.74	1.54	26.40%	-1.70%	-1.69%
TOI	ONCOLOGY INSTITUTE INC	$331.01M	-1,659.40%	-37.20%	-54.90%	-32.10%	-18.79	1.62	15.00%	-14.80%	-12.29%
OMI	OWENS & MINOR INC	$368.45M	-278.20%	-25.70%	-73.41%	-35.80%	-15.78	0.86	22.80%	-13.80%	-12.44%
HYFT	MINDWALK HOLDINGS CORP	$83.08M	-114.30%	-61.20%	-134.12%	-119.00%	0.96	2.17	56.70%	-130.20%	-143.91%
STSS	SHARPS TECHNOLOGY INC	$6.88M	-8.70%	-5.30%	9.82%	35.40%	0.18	4.35	-463.40%	-324.80%	647.18%
MREO	MEREO BIOPHARMA GROUP PLC	$308.65M	-80.00%	-66.90%	-91.42%	5,084.60%	0.16	8.13	73.60%	-9,910.00%	-10,070.00%
MBIO	MUSTANG BIO INC	$6.96M	N/A	-107.30%	-284.92%	103.30%	3.13	1.34	N/A	N/A	N/A
AGEN	AGENUS INC	$125.86M	N/A	-78.00%	168.15%	-1,029.80%	-1.47	0.06	99.40%	-162.90%	-81.58%
ALDX	ALDEYRA THERAPEUTICS INC	$303.67M	-73.60%	-50.60%	-87.88%	-115.80%	0.54	2.86	N/A	N/A	N/A
IVVD	INVIVYD INC	$134.56M	-177.90%	-91.00%	-246.45%	16,623.50%	1.08	1.33	93.40%	-238.30%	-238.33%
ICU	SEASTAR MEDICAL HOLDING CORP	$16.80M	N/A	-232.70%	-437.86%	393.00%	1.51	1.52	96.50%	-1,915.30%	-1,909.79%
UPB	UPSTREAM BIO INC	$930.48M	-37.80%	-27.70%	-25.51%	-38.70%	0.03	38.27	100.00%	-4,041.80%	-3,836.58%
ALT	ALTIMMUNE INC	$353.03M	-62.60%	-55.30%	-48.67%	-113.70%	0.18	20.44	100.00%	-584,973.30%	-587,700.00%
PBM	PSYENCE BIOMEDICAL LTD	$1.77M	-47.60%	24.00%	15.19%	-57.90%	0.09	11.04	N/A	N/A	N/A
DARE	DARE BIOSCIENCE INC	$28.17M	N/A	-103.70%	298.06%	201.40%	-2.02	0.34	-225.80%	105,099.60%	105,099.65%
CYTK	CYTOKINETICS INC	$6.02B	N/A	-43.70%	-52.14%	-29.40%	-5.75	5.99	100.00%	-3,201.50%	-2,996.11%
BNGO	BIONANO GENOMICS INC	$7.77M	-167.20%	-93.40%	-143.32%	-132.90%	0.68	1.76	5.10%	-271.00%	-270.87%
CBLL	CERIBELL INC	$416.87M	-48.40%	-28.50%	-24.62%	-58.20%	0.21	13.31	87.80%	-63.80%	-61.27%
KURA	KURA ONCOLOGY INC	$783.50M	-43.60%	-29.10%	-27.22%	-36.40%	1.04	8.07	100.00%	-267.50%	-261.86%
NTRA	NATERA INC	$22.25B	-18.30%	-11.70%	-13.23%	-25.70%	0.40	3.87	61.80%	-10.40%	-9.87%
CSTL	CASTLE BIOSCIENCES INC	$658.78M	-2.10%	-1.80%	-2.01%	-3.20%	0.20	6.85	81.00%	-2.70%	-2.86%
LIMN	LIMINATUS PHARMA INC	$37.72M	N/A	N/A	N/A	N/A	-1.31	0.23	N/A	N/A	N/A
NRXP	NRX PHARMACEUTICALS INC	$58.13M	N/A	-658.10%	94.89%	181.50%	-1.14	0.11	N/A	N/A	N/A
LUCY	INNOVATIVE EYEWEAR INC	$9.29M	-79.70%	-74.90%	-68.24%	-181.00%	0.06	18.70	18.20%	-390.90%	-390.88%
NNNN	ANBIO BIOTECHNOLOGY	$4.97B	14.80%	13.70%	13.80%	44.90%	0.10	10.71	71.90%	29.00%	28.99%
TRVI	TREVI THERAPEUTICS INC	$1.07B	-41.40%	-38.20%	-23.78%	-68.40%	0.05	22.43	N/A	N/A	N/A
NVCR	NOVOCURE LTD	$1.44B	-47.70%	-13.80%	-34.82%	-16.90%	2.57	1.45	76.40%	-27.10%	-27.42%
FGEN	FIBROGEN INC	$49.78M	N/A	-1.00%	2.42%	0.40%	-1.61	1.04	79.40%	2.80%	-0.74%
SLS	SELLAS LIFE SCIENCES GROUP INC	$171.63M	-132.50%	-92.80%	-99.82%	790.00%	0.24	4.91	N/A	N/A	N/A
KIDS	ORTHOPEDIATRICS CORP	$458.35M	-11.70%	-8.60%	-8.41%	-12.70%	0.42	6.67	71.50%	-18.90%	-17.72%
PDEX	PRO DEX INC	$110.87M	26.70%	15.00%	27.68%	21.70%	0.67	3.23	29.30%	13.50%	19.35%
CTKB	CYTEK BIOSCIENCES INC	$432.56M	-1.70%	-1.30%	-0.52%	-0.80%	0.31	5.23	54.40%	-3.30%	-1.12%
IXHL	INCANNEX HEALTHCARE INC	$17.51M	-332.20%	-144.00%	-242.50%	-406.10%	1.19	2.12	100.00%	-22,186.70%	-21,846.94%
EVOK	EVOKE PHARMA INC	$7.64M	-99.50%	-33.60%	-109.97%	267.70%	2.67	1.37	96.60%	-42.10%	-38.16%
MBX	MBX BIOSCIENCES INC	$585.26M	N/A	N/A	N/A	N/A	0.05	23.31	N/A	N/A	N/A
TLSA	TIZIANA LIFE SCIENCES LTD	$229.61M	-250.50%	-101.10%	-425.46%	-666.20%	1.87	1.02	N/A	N/A	N/A
CUPR	CUPRINA HOLDINGS (CAYMAN) LTD	$21.66M	N/A	-93.70%	35.46%	44.10%	-1.39	0.27	-6.30%	-3,229.50%	-3,152.53%
RAPT	RAPT THERAPEUTICS INC	$436.22M	-81.50%	-70.20%	-65.13%	-157.70%	0.06	21.11	N/A	N/A	N/A
CURX	CURANEX PHARMACEUTICALS INC	$21.92M	N/A	N/A	N/A	N/A	1.58	9.37	N/A	N/A	N/A
BRKR	BRUKER CORP	$4.71B	4.40%	1.30%	2.82%	3.20%	2.49	1.61	48.30%	2.30%	4.09%
CLLS	CELLECTIS SA	$243.01M	-49.80%	-15.80%	-14.49%	-13.70%	2.65	1.38	100.00%	-93.00%	-42.62%
IKT	INHIBIKASE THERAPEUTICS INC	$115.50M	-63.80%	-58.00%	-51.85%	-319.40%	0.11	10.09	N/A	N/A	N/A
IINN	INSPIRA TECHNOLOGIES OXY BHN LTD	$31.77M	-219.70%	-127.20%	-234.28%	-893.80%	0.87	2.02	N/A	N/A	N/A
PACB	PACIFIC BIOSCIENCES OF CALIFORNIA INC	$363.45M	-189.20%	-47.90%	-67.46%	-43.90%	12.43	6.92	21.40%	-337.20%	-330.88%
ONCY	ONCOLYTICS BIOTECH INC	$111.48M	-316.30%	-131.00%	-225.15%	8,462.00%	2.03	3.21	N/A	N/A	N/A
ATNM	ACTINIUM PHARMACEUTICALS INC	$50.23M	-129.60%	-57.30%	-73.96%	1,572.10%	1.67	9.35	N/A	N/A	N/A
UFPT	UFP TECHNOLOGIES INC	$1.49B	18.90%	10.50%	16.72%	22.90%	0.65	2.77	28.80%	11.40%	16.07%
TNON	TENON MEDICAL INC	$10.48M	-167.30%	-106.80%	-148.01%	-992.60%	0.66	3.86	45.40%	-429.50%	-429.45%
GNLX	GENELUX CORP	$158.49M	-93.00%	-74.20%	-94.30%	-115.30%	0.31	4.68	N/A	N/A	N/A
BLTE	BELITE BIO INC	$2.23B	-30.60%	-29.30%	-24.72%	-60.90%	0.04	24.31	N/A	N/A	N/A
APVO	APTEVO THERAPEUTICS INC	$4.93M	-675.50%	-175.70%	-223.84%	-428.90%	1.40	2.27	N/A	N/A	N/A
TNYA	TENAYA THERAPEUTICS INC	$270.54M	-93.80%	-75.70%	-90.98%	-101.70%	0.22	6.00	N/A	N/A	N/A
NTLA	INTELLIA THERAPEUTICS INC	$1.69B	-58.70%	-46.30%	-60.20%	-51.60%	0.26	4.90	100.00%	-1,154.10%	-1,154.10%
RPID	RAPID MICRO BIOSYSTEMS INC	$144.57M	-63.10%	-48.30%	-78.14%	-75.00%	0.39	3.67	7.50%	-145.60%	-152.69%
CLPT	CLEARPOINT NEURO INC	$612.61M	-94.40%	-51.60%	-39.84%	-99.60%	2.18	7.30	60.40%	-66.20%	-65.79%
ACTU	ACTUATE THERAPEUTICS INC	$142.93M	N/A	-281.80%	1,105.14%	297.40%	-3.63	0.73	N/A	N/A	N/A
LQDA	LIQUIDIA CORP	$1.88B	-223.90%	-58.50%	-69.15%	-84.80%	15.95	2.49	69.30%	-732.20%	-640.62%
MCRB	SERES THERAPEUTICS INC	$165.72M	283.90%	54.90%	76.17%	59.00%	3.36	1.57	N/A	N/A	N/A
RDY	DR REDDYS LABORATORIES LTD	$11.87B	18.40%	12.80%	21.76%	28.70%	0.47	1.92	58.50%	17.40%	24.24%
RAPP	RAPPORT THERAPEUTICS INC	$970.48M	-30.00%	-28.60%	-32.28%	-35.00%	0.08	22.75	N/A	N/A	N/A
GLPG	GALAPAGOS NV	$2.23B	N/A	N/A	N/A	N/A	0.44	8.08	N/A	N/A	N/A
ABVX	ABIVAX SA	$5.25B	-499.80%	-96.70%	-2,429.06%	-391.00%	-3.48	0.77	100.00%	-2,530.60%	-2,293.15%
HURA	TUHURA BIOSCIENCES INC	$123.12M	-277.90%	-172.70%	-137.59%	-3,839.60%	0.78	0.83	N/A	N/A	N/A
ANAB	ANAPTYSBIO INC	$660.17M	-367.00%	-30.60%	-44.21%	-20.90%	-8.49	8.22	100.00%	-107.70%	-107.59%
CRVS	CORVUS PHARMACEUTICALS INC	$550.66M	-103.40%	-65.30%	-55.75%	-122.30%	0.12	8.91	N/A	N/A	N/A
XLO	XILIO THERAPEUTICS INC	$41.26M	-399.20%	-58.70%	-69.80%	263.80%	17.93	2.32	100.00%	-374.80%	-374.79%
MASS	908 DEVICES INC	$289.05M	-13.30%	-10.20%	-11.43%	-30.90%	0.29	4.98	48.60%	-30.50%	-30.65%
OMER	OMEROS CORP	$303.53M	N/A	-47.70%	-96.97%	-18.90%	-1.88	0.82	N/A	N/A	N/A
PYXS	PYXIS ONCOLOGY INC	$132.72M	-82.80%	-63.00%	-93.02%	-74.20%	0.41	5.65	100.00%	-3,414.40%	-3,481.10%
AUTL	AUTOLUS THERAPEUTICS PLC	$415.18M	-56.20%	-29.60%	-36.84%	-33.00%	1.08	8.43	-79.70%	-760.90%	-803.46%
NEUP	NEUPHORIA THERAPEUTICS INC	$23.14M	N/A	N/A	N/A	N/A	0.18	11.01	N/A	N/A	N/A
MGRX	MANGOCEUTICALS INC	$22.76M	-85.00%	-78.10%	-74.86%	1,295.80%	0.08	0.07	61.00%	-2,752.30%	-2,791.27%
BKD	BROOKDALE SENIOR LIVING INC	$1.98B	-128.10%	-3.90%	0.11%	0.10%	57.27	0.83	19.60%	-7.60%	0.19%
AIMD	AINOS INC	$16.21M	-108.30%	-56.90%	-63.96%	-142.60%	1.09	2.88	82.30%	-14,182.70%	-13,453.71%
CVM	CEL SCI CORP	$61.60M	-259.40%	-107.20%	-167.96%	-105.40%	1.90	0.47	N/A	N/A	N/A
SGHT	SIGHT SCIENCES INC	$179.92M	-54.60%	-34.90%	-37.78%	-92.50%	0.67	10.47	85.70%	-63.20%	-56.86%
ZNTL	ZENTALIS PHARMACEUTICALS INC	$111.81M	-51.60%	-40.30%	-52.13%	-46.30%	0.28	7.99	100.00%	401.30%	401.91%
TLX	TELIX PHARMACEUTICALS LTD	$3.34B	13.90%	5.20%	7.84%	27.90%	1.67	2.78	65.10%	6.40%	11.87%
SINT	SINTX TECHNOLOGIES INC	$12.53M	-256.60%	-121.30%	-177.55%	-171.90%	1.31	2.57	19.80%	-674.00%	-671.36%
OCGN	OCUGEN INC	$426.76M	-255.30%	-86.80%	-154.39%	-168.00%	16.56	1.83	100.00%	-1,197.70%	-1,156.27%
SEPN	SEPTERNA INC	$778.01M	-31.50%	-23.60%	-21.94%	-43.90%	0.10	22.09	100.00%	-12,053.00%	-12,093.80%
STIM	NEURONETICS INC	$179.20M	-195.80%	-39.70%	-38.77%	-33.70%	3.80	2.02	56.20%	-43.90%	-37.28%
NRIX	NURIX THERAPEUTICS INC	$682.69M	-45.30%	-34.70%	-40.02%	-45.80%	0.32	6.82	100.00%	-234.60%	-233.61%
FATE	FATE THERAPEUTICS INC	$115.33M	-55.70%	-40.20%	-50.01%	-39.90%	0.42	8.04	100.00%	-2,025.10%	-2,025.05%
LAB	STANDARD BIOTOOLS INC	$496.59M	-26.20%	-19.80%	-25.61%	-40.00%	0.31	5.16	49.00%	-78.10%	-76.21%
NUVB	NUVATION BIO INC	$1.09B	-147.60%	-110.30%	-137.81%	-130.20%	0.17	9.01	16.30%	-5,534.20%	-5,530.60%
IBRX	IMMUNITYBIO INC	$2.40B	N/A	-101.00%	-65.87%	-22.10%	-1.70	4.11	99.70%	-648.60%	-408.99%
IPSC	CENTURY THERAPEUTICS INC	$43.97M	-11.50%	-6.90%	-7.97%	-8.70%	0.36	10.72	100.00%	-20.40%	-18.85%
DNA	GINKGO BIOWORKS HOLDINGS INC	$673.12M	-63.10%	-32.70%	-40.11%	-41.90%	1.00	4.88	80.00%	-198.80%	-198.98%
RMTI	ROCKWELL MEDICAL INC	$43.73M	-6.80%	-3.80%	-2.29%	-2.90%	0.73	2.89	17.50%	-2.40%	-1.09%
BIVI	BIOVIE INC	$14.01M	-90.90%	-76.90%	-89.23%	2,537.90%	0.13	9.10	N/A	N/A	N/A
AYTU	AYTU BIOPHARMA INC	$17.25M	-47.40%	-11.30%	-15.42%	-246.30%	5.55	1.26	69.00%	-20.40%	-14.19%
VSTM	VERASTEM INC	$488.50M	N/A	-128.00%	-150.99%	-447.30%	-5.06	3.50	100.00%	-1,488.80%	-1,450.68%
NKTX	NKARTA INC	$144.89M	-27.70%	-22.40%	-25.44%	-21.90%	0.25	15.67	N/A	N/A	N/A
IFRX	INFLARX NV	$88.07M	-71.30%	-57.30%	-79.02%	-117.80%	0.29	4.10	-3,067.30%	-27,815.70%	-27,802.02%

Healthcare Industries

Industry	Stocks	1d %	1w %	1m %	1y %	P/E ratio	P/B Ratio	ROE	ROA	ROCE	Upside/Downside	Consensus
Biotechnology	634	+1.79%	+1.91%	+6.43%	-34.10%	-103.63x	4.74x	-110.35%	-7.14%	-11.38%	+74.80%	Strong Buy
Diagnostics & Research	56	+1.01%	-2.91%	-2.11%	-20.34%	20.19x	3.68x	-3.05%	+7.21%	+15.74%	+12.47%	Strong Buy
Drug Manufacturers - General	19	+1.12%	-2.43%	-1.22%	-11.24%	36.82x	5.90x	+60.33%	+10.39%	+17.87%	+44.86%	Buy
Drug Manufacturers - Specialty & Generic	76	+0.80%	-1.60%	+0.72%	-14.92%	-26.18x	2.19x	+11.47%	+4.52%	+9.99%	+34.64%	Buy
Healthcare Plans	11	+0.51%	+2.09%	+1.67%	-31.43%	14.69x	2.04x	+15.83%	+4.97%	+11.53%	+16.07%	Buy
Health Information Services	53	+1.70%	-0.25%	-0.80%	-51.95%	79.61x	4.19x	+8.45%	+5.32%	+9.21%	+27.22%	Strong Buy
Medical Care Facilities	47	+1.83%	+4.11%	+3.99%	-27.10%	16.54x	5.02x	-187.08%	+6.89%	+15.30%	+13.48%	Buy
Medical Devices	142	+0.34%	-2.25%	-5.08%	-29.83%	30.11x	3.93x	+13.92%	+8.58%	+10.09%	+31.97%	Strong Buy
Medical Distribution	10	+2.95%	+6.64%	+8.45%	+42.42%	28.76x	311.71x	-10.64%	+3.09%	+19.03%	+11.15%	Buy
Medical Instruments & Supplies	55	+1.38%	-1.61%	-4.20%	-63.95%	29.83x	3.29x	+10.52%	+8.43%	+11.16%	+28.03%	Buy

Healthcare Stocks FAQ

What are the best healthcare stocks to buy right now in Sep 2025?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best healthcare stocks to buy right now are:

1. Theravance Biopharma (NASDAQ:TBPH)

Theravance Biopharma (NASDAQ:TBPH) is the #1 top healthcare stock out of 1103 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Theravance Biopharma (NASDAQ:TBPH) is: Value: B, Growth: A, Momentum: C, Sentiment: B, Safety: D, Financials: A, and AI: B.

Theravance Biopharma (NASDAQ:TBPH) has a Due Diligence Score of 39, which is 14 points higher than the healthcare sector average of 25. It passed 12 out of 33 due diligence checks and has average fundamentals. Theravance Biopharma has seen its stock return 74.57% over the past year, overperforming other healthcare stocks by 108 percentage points.

Theravance Biopharma has an average 1 year price target of $25.67, an upside of 82.42% from Theravance Biopharma's current stock price of $14.07.

Theravance Biopharma stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Theravance Biopharma, 100% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Embecta (NASDAQ:EMBC)

Embecta (NASDAQ:EMBC) is the #2 top healthcare stock out of 1103 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Embecta (NASDAQ:EMBC) is: Value: A, Growth: A, Momentum: C, Sentiment: B, Safety: D, Financials: A, and AI: C.

Embecta (NASDAQ:EMBC) has a Due Diligence Score of 35, which is 10 points higher than the healthcare sector average of 25. It passed 12 out of 38 due diligence checks and has average fundamentals. Embecta has seen its stock lose -4.34% over the past year, overperforming other healthcare stocks by 29 percentage points.

Embecta has an average 1 year price target of $18.50, an upside of 33.09% from Embecta's current stock price of $13.90.

Embecta stock has a consensus Buy recommendation according to Wall Street analysts. Of the 2 analysts covering Embecta, 50% have issued a Strong Buy rating, 0% have issued a Buy, 50% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Infusystem Holdings (NYSEMKT:INFU)

Infusystem Holdings (NYSEMKT:INFU) is the #3 top healthcare stock out of 1103 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Infusystem Holdings (NYSEMKT:INFU) is: Value: C, Growth: B, Momentum: B, Sentiment: A, Safety: C, Financials: A, and AI: C.

Infusystem Holdings (NYSEMKT:INFU) has a Due Diligence Score of 29, which is 4 points higher than the healthcare sector average of 25. It passed 9 out of 33 due diligence checks and has average fundamentals. Infusystem Holdings has seen its stock return 57.62% over the past year, overperforming other healthcare stocks by 91 percentage points.

Infusystem Holdings has an average 1 year price target of $13.50, an upside of 30.56% from Infusystem Holdings's current stock price of $10.34.

Infusystem Holdings stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 2 analysts covering Infusystem Holdings, 100% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the healthcare stocks with highest dividends?

Out of 72 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

1. Select Medical Holdings (NYSE:SEM)

Select Medical Holdings (NYSE:SEM) has an annual dividend yield of 14.55%, which is 12 percentage points higher than the healthcare sector average of 2.08%. Select Medical Holdings's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Select Medical Holdings's dividend has not shown consistent growth over the last 10 years.

Select Medical Holdings's dividend payout ratio of 35.1% indicates that its high dividend yield is sustainable for the long-term.

2. Cryo Cell International (NYSEMKT:CCEL)

Cryo Cell International (NYSEMKT:CCEL) has an annual dividend yield of 8.33%, which is 6 percentage points higher than the healthcare sector average of 2.08%.

Cryo Cell International's dividend payout ratio of -2,166.7% indicates that its high dividend yield might not be sustainable for the long-term.

3. Dominari Holdings (NASDAQ:DOMH)

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 7.89%, which is 6 percentage points higher than the healthcare sector average of 2.08%.

Dominari Holdings's dividend payout ratio of -13.4% indicates that its high dividend yield might not be sustainable for the long-term.

Why are healthcare stocks up?

Healthcare stocks were up 1.36% in the last day, and up 0.15% over the last week. Bioaffinity Technologies was the among the top gainers in the healthcare sector, gaining 55.13% yesterday.

bioAffinity Technologies shares are trading lower after the company priced a $4.8M public offering of ~1.92M shares or pre-funded warrants at $2.50 per share.

What are the most undervalued healthcare stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued healthcare stocks right now are:

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 71, which is 55 points higher than the healthcare sector average of 16. It passed 5 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has dropped -30.86% in the past year. It has overperformed other stocks in the healthcare sector by 2 percentage points.

2. Embecta (NASDAQ:EMBC)

Embecta (NASDAQ:EMBC) is the second most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Embecta has a valuation score of 57, which is 41 points higher than the healthcare sector average of 16. It passed 4 out of 7 valuation due diligence checks.

Embecta's stock has dropped -4.34% in the past year. It has overperformed other stocks in the healthcare sector by 29 percentage points.

3. Puma Biotechnology (NASDAQ:PBYI)

Puma Biotechnology (NASDAQ:PBYI) is the third most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Puma Biotechnology has a valuation score of 43, which is 27 points higher than the healthcare sector average of 16. It passed 3 out of 7 valuation due diligence checks.

Puma Biotechnology's stock has gained 89.06% in the past year. It has overperformed other stocks in the healthcare sector by 122 percentage points.

Are healthcare stocks a good buy now?

52.17% of healthcare stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare stocks to rise by 40.4% over the next year.

5.3% of healthcare stocks have a Zen Rating of A (Strong Buy), 12.13% of healthcare stocks are rated B (Buy), 46.64% are rated C (Hold), 24.62% are rated D (Sell), and 11.31% are rated F (Strong Sell).

What is the average p/e ratio of the healthcare sector?

The average P/E ratio of the healthcare sector is 7.98x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2025)
Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Theravance Biopharma (NASDAQ:TBPH)

2. Embecta (NASDAQ:EMBC)

3. Infusystem Holdings (NYSEMKT:INFU)

1. Select Medical Holdings (NYSE:SEM)

2. Cryo Cell International (NYSEMKT:CCEL)

3. Dominari Holdings (NASDAQ:DOMH)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Embecta (NASDAQ:EMBC)

3. Puma Biotechnology (NASDAQ:PBYI)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBest Healthcare Stocks to Buy Now (2025)Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Theravance Biopharma (NASDAQ:TBPH)

2. Embecta (NASDAQ:EMBC)

3. Infusystem Holdings (NYSEMKT:INFU)

1. Select Medical Holdings (NYSE:SEM)

2. Cryo Cell International (NYSEMKT:CCEL)

3. Dominari Holdings (NASDAQ:DOMH)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Embecta (NASDAQ:EMBC)

3. Puma Biotechnology (NASDAQ:PBYI)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2025)
Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.